ACGL stock touches 52-week low at $84.32 amid market shifts

Published 07/04/2025, 15:54
ACGL stock touches 52-week low at $84.32 amid market shifts

Arch Capital Group Ltd. (NASDAQ:ACGL), a $31.9 billion market cap insurance giant, has experienced a notable downturn, touching a 52-week low of $84.32. This latest price level reflects a challenging period for the company, with an 8.68% decline just last week, despite maintaining a "GREAT" financial health score according to InvestingPro analysis. Over the past year, Arch Capital Group has witnessed a decline of 4.77% in its stock value, trading at an attractive P/E ratio of 7.68. As stakeholders and analysts observe these movements, the 52-week low serves as a critical benchmark for evaluating the company's performance. InvestingPro's Fair Value analysis suggests the stock is currently undervalued, with comprehensive insights available in the Pro Research Report covering this prominent insurance player.

In other recent news, Arch Capital reported fourth-quarter earnings that exceeded analyst expectations, with adjusted earnings per share reaching $2.26 compared to the anticipated $1.84. The company also reported revenue of $4.76 billion, surpassing the $4.03 billion estimate. Gross premiums written saw an 11.9% year-over-year increase, totaling $4.76 billion, while net premiums written rose 17.1% to $3.82 billion. Despite pre-tax catastrophe losses of $393 million due to Hurricanes Milton and Helene, Arch Capital maintained a combined ratio of 85.0%. Meanwhile, RBC Capital Markets adjusted Arch Capital's price target to $110 from $125, citing a strong year-end performance despite challenges, while maintaining an Outperform rating. Keefe, Bruyette & Woods also reaffirmed an Outperform rating with a price target of $113, reflecting on the company's reserve releases and earnings estimates for 2025 and 2026. JMP Securities maintained a price target of $125, highlighting Arch Capital's strategic positioning and strong balance sheet. These developments indicate a continued positive outlook from analysts despite some challenges in the insurance market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.